MIST - Milestone Pharmaceuticals Inc
IEX Last Trade
1.425
0.005 0.351%
Share volume: 39,716
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$1.42
0.01
0.35%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
| Report Date | 2022-05-12 | 2022-08-10 | 2022-11-10 | 2023-03-29 | 2023-05-11 | 2023-08-10 | 2023-11-13 | 2024-03-21 | |
| Assets | |||||||||
| Total Assets | 105.799 M | 91.299 M | 85.769 M | 74.483 M | 111.080 M | 97.019 M | 87.116 M | 75.226 M | |
| Current Assets | 104.966 M | 90.502 M | 82.921 M | 71.803 M | 108.508 M | 94.566 M | 84.797 M | 73.032 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 4.725 M | 4.265 M | 5.688 M | 7.218 M | 6.555 M | 6.975 M | 9.051 M | 7.029 M | |
| Short Term Investments | 4.725 M | 4.265 M | 5.688 M | 7.218 M | 6.555 M | 6.975 M | 9.051 M | 7.029 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 1.000 M | 0.000 | 0.000 | 0.000 | |
| Current Cash | 100.241 M | 86.237 M | 77.233 M | 64.585 M | 100.953 M | 87.591 M | 75.746 M | 66.003 M | |
| Total Non-current Assets | 833.000 K | 797.000 K | 2.848 M | 2.680 M | 2.572 M | 2.453 M | 2.319 M | 2.194 M | |
| Property Plant Equipment | 192.000 K | 227.000 K | 303.000 K | 257.000 K | 272.000 K | 278.000 K | 272.000 K | 277.000 K | |
| Other Assets | 641.000 K | 570.000 K | 2.545 M | 2.423 M | 2.300 M | 2.175 M | 2.047 M | 1.917 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 105.799 M | 91.299 M | 85.769 M | 74.483 M | 111.080 M | 97.019 M | 87.116 M | 75.226 M | |
| Total liabilities | 5.043 M | 4.640 M | 8.614 M | 8.135 M | 57.145 M | 56.611 M | 58.612 M | 58.455 M | |
| Total current liabilities | 4.610 M | 4.256 M | 6.522 M | 6.139 M | 7.963 M | 6.809 M | 8.114 M | 7.226 M | |
| Accounts Payable | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 198.000 K | 169.000 K | 487.000 K | 495.000 K | 507.000 K | 522.000 K | 530.000 K | 546.000 K | |
| Long term debt | 433.000 K | 384.000 K | 2.092 M | 1.996 M | 49.182 M | 49.802 M | 50.498 M | 51.229 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 100.756 M | 86.659 M | 77.155 M | 66.348 M | 53.935 M | 40.408 M | 28.504 M | 16.771 M | |
| Common stock | 42.243 M | 42.279 M | 42.492 M | 42.788 M | 42.853 M | 42.937 M | 42.973 M | 43.060 M | |
| Retained earnings | -220.326 M | -236.974 M | -251.530 M | -266.341 M | -281.291 M | -297.334 M | -312.415 M | -326.026 M |